Krabbe Disease
Oncology
Prevalence
5.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| plx-300 | Polaryx Therapeutics Inc. (PLYX) |
Frequently asked questions
How many drugs are in development for Krabbe Disease?
BioSniper tracks 1 drug in development for Krabbe Disease across 1 company.
How many clinical trials target Krabbe Disease?
There are 2 clinical trials targeting Krabbe Disease tracked by BioSniper.
What is the prevalence of Krabbe Disease?
The estimated prevalence of Krabbe Disease is approximately 5.0 per 100,000 population.
Deep-dive into Krabbe Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis